Is There a Reduction in Perioperative COVID-19 Infection in Patients Undergoing Foot and Ankle Surgery in Designated COVID-19 Green Pathways? Results from Phase 1 and 2 of the Foot and Ankle COVID-19 National (UK-FAICoN) Audit

Description

In this VTT transcript, Dr. Jitendra Mangwani from Leicester presents findings on a collaborative work focused on the reduction of perioperative COVID-19 infections in patients undergoing foot and ankle surgery. Representing the UK Falcon Group, he discusses the results of national audits that tracked COVID-19 incidence and related mortality among foot and ankle surgery patients during two phases: a retrospective analysis and a prospective data collection phase. Dr. Mangwani highlights a significant decrease in COVID-19 infection rates and associated mortality, especially between the two study phases, with initial rates showing a notable reduction from 25% in the first phase to 4.65% in the second. He emphasizes the relevance of 'green' (safeguarded) and 'blue' (standard) treatment pathways, revealing no differences in mortality rates between them in the later phase. The presentation concludes with acknowledgments of the support and contributions received during the study, followed by an interactive Q&A session where further queries regarding the influence of increased staff testing and the impact of vaccination timelines on results are addressed.

DOI: 10.1302/3114-221399

Specialties

Conferences